TD Cowen is Bullish on Alignment Healthcare, Inc. (ALHC) After Medicare Advantage Update

We recently compiled a list of the 15 High Growth Mid-Cap Stocks to Buy. The seventh stock on our list of high growth stocks is Alignment Healthcare, Inc.

TheFly reported on January 16 that TD Cowen raised its price target on ALHC to $25 from $18.50 and maintained a Buy rating. The firm revised its model in response to information from a recent investor presentation and pointed out that Medicare Advantage enrollment is not anticipated to significantly surpass the estimated +20% growth rate and that FY2026 consensus EBITDA stays within the previous forecast range.

In addition, Alignment Healthcare, Inc. (NASDAQ:ALHC) revealed on January 12 that as of January 1, 2026, there were about 275,300 health plan subscribers, a 31% increase from the previous year. The organization offered recommendations for 290,000–296,000 members by the end of 2026. In order to stay within its full-year projection range, Alignment also anticipates consensus adjusted EBITDA of about $145 million in 2026.

Alignment Healthcare, Inc. (NASDAQ:ALHC) is a tech‑enabled U.S. Medicare Advantage company delivering personalized health plans and coordinated care for seniors and chronically ill members. It combines data‑driven clinical management and proprietary technology to improve outcomes, lower costs, and expand high‑quality Medicare Advantage services across multiple states.

While we acknowledge the potential of ALHC as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 12 Best Multibagger Stocks to Buy Heading into 2026 and 7 Best Rising Tech Stocks to Buy Now.

Disclosure: None.